{{Rsnum
|rsid=1383139
|Chromosome=15
|position=98174448
|Orientation=minus
|GMAF=0.4073
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 51.3 | 26.5
| HCB | 13.9 | 40.1 | 46.0
| JPT | 7.1 | 37.2 | 55.8
| YRI | 25.9 | 44.2 | 29.9
| ASW | 19.3 | 47.4 | 33.3
| CHB | 13.9 | 40.1 | 46.0
| CHD | 16.5 | 46.8 | 36.7
| GIH | 30.0 | 48.0 | 22.0
| LWK | 18.2 | 40.9 | 40.9
| MEX | 12.1 | 43.1 | 44.8
| MKK | 12.8 | 57.1 | 30.1
| TSI | 18.6 | 51.0 | 30.4
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1383139
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363832
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1383139
|overall_frequency_n=71
|overall_frequency_d=128
|overall_frequency=0.554688
|n_genomes=47
|n_genomes_annotated=0
|n_haplomes=66
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}